FI772066A - - Google Patents

Info

Publication number
FI772066A
FI772066A FI772066A FI772066A FI772066A FI 772066 A FI772066 A FI 772066A FI 772066 A FI772066 A FI 772066A FI 772066 A FI772066 A FI 772066A FI 772066 A FI772066 A FI 772066A
Authority
FI
Finland
Application number
FI772066A
Other languages
Finnish (fi)
Other versions
FI58136C (fi
FI58136B (fi
Inventor
Welf Von Daehne
Poul Roedbroe Rasmussen
Original Assignee
Leo Pharm Prod Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Leo Pharm Prod Ltd filed Critical Leo Pharm Prod Ltd
Publication of FI772066A publication Critical patent/FI772066A/fi
Application granted granted Critical
Publication of FI58136B publication Critical patent/FI58136B/fi
Publication of FI58136C publication Critical patent/FI58136C/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J41/00Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0005Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring the nitrogen atom being directly linked to the cyclopenta(a)hydro phenanthrene skeleton
    • C07J41/0027Azides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J13/00Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double bond from or to position 17
    • C07J13/007Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double bond from or to position 17 with double bond in position 17 (20)
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J31/00Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
    • C07J31/003Normal steroids containing one or more sulfur atoms not belonging to a hetero ring the S atom directly linked to a ring carbon atom of the cyclopenta(a)hydrophenanthrene skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J31/00Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
    • C07J31/006Normal steroids containing one or more sulfur atoms not belonging to a hetero ring not covered by C07J31/003
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J33/00Normal steroids having a sulfur-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J33/002Normal steroids having a sulfur-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton not condensed
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J41/00Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0005Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring the nitrogen atom being directly linked to the cyclopenta(a)hydro phenanthrene skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J43/00Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J43/003Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton not condensed
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J51/00Normal steroids with unmodified cyclopenta(a)hydrophenanthrene skeleton not provided for in groups C07J1/00 - C07J43/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
FI772066A 1976-07-05 1977-07-01 Foerfarande foer framstaellning av terapeutiskt anvaendbara 16-deacetoxi-16alfa-acyltiofusidinsyraderivat FI58136C (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB27921/76A GB1581335A (en) 1976-07-05 1976-07-05 16-s-acyl derivatives of fusidic acid
GB2792176 1976-07-05

Publications (3)

Publication Number Publication Date
FI772066A true FI772066A (de) 1978-01-06
FI58136B FI58136B (fi) 1980-08-29
FI58136C FI58136C (fi) 1980-12-10

Family

ID=10267438

Family Applications (1)

Application Number Title Priority Date Filing Date
FI772066A FI58136C (fi) 1976-07-05 1977-07-01 Foerfarande foer framstaellning av terapeutiskt anvaendbara 16-deacetoxi-16alfa-acyltiofusidinsyraderivat

Country Status (22)

Country Link
US (1) US4119717A (de)
JP (1) JPS535152A (de)
AT (1) AT354625B (de)
AU (1) AU516152B2 (de)
BE (1) BE856464A (de)
CA (1) CA1100941A (de)
DE (1) DE2730196C2 (de)
DK (1) DK148390B (de)
FI (1) FI58136C (de)
FR (1) FR2357574A1 (de)
GB (1) GB1581335A (de)
GR (1) GR63210B (de)
IE (1) IE45217B1 (de)
IT (1) IT1083082B (de)
LU (1) LU77683A1 (de)
NL (1) NL7707221A (de)
NZ (1) NZ184408A (de)
PH (1) PH14058A (de)
PT (1) PT66759B (de)
SE (1) SE436752B (de)
YU (1) YU165477A (de)
ZA (1) ZA773739B (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4162259A (en) * 1975-12-03 1979-07-24 Leo Pharmaceutical Products Ltd. A/S (Lovens Kemiske fabrik Produktionsaktienselskab) Fusidic acid derivatives
US4548922A (en) * 1983-06-06 1985-10-22 Beth Israel Hospital Drug administration
US4746508A (en) * 1983-06-06 1988-05-24 Beth Israel Hospital Assn. Drug administration
US4959358A (en) * 1983-06-06 1990-09-25 Beth Israel Hospital Assn. Drug administration
US4994439A (en) * 1989-01-19 1991-02-19 California Biotechnology Inc. Transmembrane formulations for drug administration
GB9518883D0 (en) * 1995-09-15 1995-11-15 Leo Pharm Prod Ltd Chemical compounds
MY140194A (en) * 2003-07-16 2009-11-30 Leo Pharma As Novel fusidic acid derivatives
JP5268917B2 (ja) * 2006-09-19 2013-08-21 アボット プロダクツ ゲゼルシャフト ミット ベシュレンクテル ハフツング 治療学的に有効なトリアゾール類及びそれらの使用
PT106679B (pt) 2012-11-27 2015-03-25 Hovione Farmaciencia Sa Formulações tópicas de tetraciclinas, sua preparação e usos

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1490852A (en) * 1974-09-12 1977-11-02 Leo Pharm Prod Ltd Fusidic acid derivatives
GR60362B (en) * 1975-06-25 1978-05-19 Leo Pharm Prod Ltd Preparation process of new 16-ethers of fusidic acid derivatives
US4060606A (en) * 1975-06-25 1977-11-29 Leo Pharmaceutical Products Ltd. A/S 16-Ethers of fusidic acid derivatives

Also Published As

Publication number Publication date
FI58136C (fi) 1980-12-10
JPS535152A (en) 1978-01-18
AU2643877A (en) 1979-01-04
JPS6238360B2 (de) 1987-08-17
LU77683A1 (de) 1978-01-31
DE2730196C2 (de) 1987-03-05
CA1100941A (en) 1981-05-12
PH14058A (en) 1980-12-29
FI58136B (fi) 1980-08-29
DK148390B (da) 1985-06-24
BE856464A (fr) 1978-01-04
NZ184408A (en) 1980-04-28
PT66759A (en) 1977-08-01
DK294177A (da) 1978-01-06
NL7707221A (nl) 1978-01-09
GR63210B (en) 1979-10-08
US4119717A (en) 1978-10-10
GB1581335A (en) 1980-12-10
ZA773739B (en) 1978-05-30
SE436752B (sv) 1985-01-21
YU165477A (en) 1982-06-30
DE2730196A1 (de) 1978-01-19
IT1083082B (it) 1985-05-21
AT354625B (de) 1979-01-25
SE7707749L (sv) 1978-01-06
ATA455777A (de) 1979-06-15
FR2357574B1 (de) 1979-07-20
IE45217B1 (en) 1982-07-14
IE45217L (en) 1978-01-05
PT66759B (en) 1978-12-14
FR2357574A1 (fr) 1978-02-03
AU516152B2 (en) 1981-05-21

Similar Documents

Publication Publication Date Title
JPS5617261B2 (de)
FR2373614B1 (de)
FR2357574B1 (de)
JPS5541780B2 (de)
FR2372887B1 (de)
JPS5336389U (de)
JPS5337851U (de)
JPS5385208U (de)
JPS5352050U (de)
JPS5349122U (de)
JPS52107678U (de)
JPS52108226U (de)
FR2339260B1 (de)
JPS5719659B2 (de)
JPS52148713U (de)
JPS5336646U (de)
JPS5364294U (de)
JPS5363435U (de)
JPS5360754U (de)
JPS538087U (de)
JPS52111185U (de)
JPS52133033U (de)
JPS537371U (de)
JPS52144086U (de)
CH597484A5 (de)

Legal Events

Date Code Title Description
MM Patent lapsed

Owner name: LEO PHARMACEUTICAL PRODUCTS LTD A/S (LOEVENS KEMIS